Prioritizing treatment outcomes: How people with acne vulgaris decide if their treatment is working
| Autor: | Alison M. Layton, Katharine L. Warburton, Heather Whitehouse, Mark Fenton, Fiona Cowdell, E. Anne Eady |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Self-assessment
medicine.medical_specialty business.industry Health Policy Treatment outcome Alternative medicine General Medicine medicine.disease Outcome (game theory) Surgery Visual inspection 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Mood Family medicine medicine 030212 general & internal medicine business Psychosocial Acne |
| Zdroj: | Journal of Evidence-Based Medicine. 10:163-170 |
| ISSN: | 1756-5391 |
| DOI: | 10.1111/jebm.12249 |
| Popis: | Aim To collect information about how people with acne make day-to-day decisions concerning the effectiveness of their treatment. Methods Between May and August 2013, an optional question was embedded in the James Lind Alliance Acne Priority Setting Partnership's online survey to collect treatment uncertainties. The question asked people with acne to ‘Tell us in your own words how you decide if your treatment has been effective’. Results A total of 742 respondents specified at least one outcome or means of assessing change (outcome measure). Fewer spots was the most commonly cited outcome, identified by 272 respondents (36.7%). Other frequently mentioned outcomes were, in descending order: less redness (19.4%), reduction in spot size (12.1%) and less pain/discomfort (11.4%). Signs were much more commonly used than symptoms and surrogate outcomes such as changes in aspects of life quality were infrequently mentioned. Visual inspection of the skin was the most widely adopted outcome measure (16.3%). Conclusions Although the most frequently used methods map well onto the outcome measures adopted in the majority of acne trials, namely physician-assessed changes in lesion counts and global acne severity, people with acne often take into account several factors that cannot be assessed by a third party at a single point in time. The minimal use of changes in psychosocial wellbeing and mood may reflect that these are regarded as secondary consequences of improvements in appearance. The robustness of these findings now requires independent evaluation. If confirmed, they could form the basis of a new patient-reported outcome measure. This article is protected by copyright. All rights reserved |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text